These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1172408)

  • 21. Differential effects of E-5-(2-bromovinyl)-2'-deoxyuridine on infections with herpes simplex virus type 1 and type 2 in hairless mice.
    De Clercq E; Zhen-Xi Zhang
    J Infect Dis; 1982 Jan; 145(1):130. PubMed ID: 7054316
    [No Abstract]   [Full Text] [Related]  

  • 22. HERPES SIMPLEX SKIN INFECTION IN RABBITS. I. EFFECT OF 5-IODO-2'-DEOXYURIDINE.
    FORCE EE; STEWART RC; HAFF RF
    Virology; 1964 Jul; 23():363-9. PubMed ID: 14194130
    [No Abstract]   [Full Text] [Related]  

  • 23. Herpes simplex.
    Dudgeon JA
    Mod Trends Med Virol; 1970; 2(0):78-115. PubMed ID: 4365429
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapeutic efficacy of E-5-(2-bromovinyl)-2'deoxyuridine for orofacial infection with herpes simplex virus type 1 in mice.
    Park NH; Pavan-Langston D; Boisjoly HM; De Clercq E
    J Infect Dis; 1982 Jun; 145(6):909-13. PubMed ID: 6979592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of idoxuridine on herpes simplex virus infection in mouse skin.
    Robinson TW; Hough V
    Trans St Johns Hosp Dermatol Soc; 1975; 61(1-2):44-50. PubMed ID: 173053
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antiherpetic vaccine and ointment with 5-iodo-2-deoxyuridine in cutaneous-mucous recurrent herpes simplex. Comparative results].
    Macotela-Ruíz E
    Prensa Med Mex; 1973; 38(9):362-7. PubMed ID: 4793470
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities and limits of chemotherapy of diseases caused by herpes simplex and varicella-zoster virus].
    Wassilew SW
    Hautarzt; 1983 Jan; 34(1):1-5. PubMed ID: 6841073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of 5-iodo-2'-deoxyuridine (IUDR) in Orabase and plastibase for treatment of oral herpes simplex.
    Najjar TA; Sleeper HR; Calabresi P
    J Oral Med; 1969 Apr; 24(2):53-7. PubMed ID: 4308869
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.
    Herrmann EC
    Appl Microbiol; 1968 Aug; 16(8):1151-5. PubMed ID: 4300089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Meldrum JB; Gupta VS; Babiuk LA
    Chemotherapy; 1980; 26(1):54-63. PubMed ID: 7353440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes simplex encephalitis in Hodgkins disease. Isolation of drug-sensitive virus from brain following unsuccessful treatment with idoxuridine.
    Heineman HS; Breen FA
    Cancer; 1975 Oct; 36(4):1344-7. PubMed ID: 169986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Herpes simplex encephalitis in newborns. Treatment with 5-iodo-2'-deoxyuridin? (author's transl)].
    Nüssli R; Kind HP; Duc G
    Eur J Pediatr; 1976 May; 122(2):131-7. PubMed ID: 944631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes simplex virus skin infection in man treated with idoxuridine in dimethyl sulphoxide. Results of double-blind controlled trial.
    MacCallum FO; Juel-Jensen BE
    Br Med J; 1966 Oct; 2(5517):805-7. PubMed ID: 5331424
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutics. XIV. Herpes simplex virus infections and idoxuridine.
    Ashton H; Frenk E; Stevenson CJ
    Br J Dermatol; 1971 May; 84(5):496-9. PubMed ID: 4932957
    [No Abstract]   [Full Text] [Related]  

  • 35. High efficiency latency and activation of herpes simplex virus in human cells.
    Wigdahl BL; Scheck AC; De Clercq E; Rapp F
    Science; 1982 Sep; 217(4565):1145-6. PubMed ID: 6180477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes simplex virus encephalitis treated with idoxuridine.
    Buckley TF; MacCallum FO
    Br Med J; 1967 May; 2(5549):419-20. PubMed ID: 6022037
    [No Abstract]   [Full Text] [Related]  

  • 37. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
    Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
    Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activity of iododeoxyuridine, adenine arabinoside, cytosine arabinoside, ribavirin and phosphonoacetic acid against herpes virus in the hairless mouse model.
    Harris SR; Boyd MR
    J Antimicrob Chemother; 1977 Mar; 3 Suppl A():91-8. PubMed ID: 193825
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of lithium as an inhibitory agent of herpes simplex virus in cell cultures and during reactivation of latent infection in rabbits.
    Trousdale MD; Gordon YJ; Peters AC; Gropen TI; Nelson E; Nesburn AB
    Antimicrob Agents Chemother; 1984 Apr; 25(4):522-3. PubMed ID: 6329084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    Epstein AH; Cook JA; Goffman T; Glatstein E
    BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.